Hsp90 phosphorylation, Wee1 and the cell cycle
- PMID: 20519952
- PMCID: PMC7316391
- DOI: 10.4161/cc.9.12.12054
Hsp90 phosphorylation, Wee1 and the cell cycle
Abstract
Heat Shock Protein 90 (Hsp90) is an essential molecular chaperone in eukaryotic cells, and it maintains the functional conformation of a subset of proteins that are typically key components of multiple regulatory and signaling networks mediating cancer cell proliferation, survival, and metastasis. It is possible to selectively inhibit Hsp90 using natural products such as geldanamycin (GA) or radicicol (RD), which have served as prototypes for development of synthetic Hsp90 inhibitors. These compounds bind within the ADP/ATP-binding site of the Hsp90 N-terminal domain to inhibit its ATPase activity. As numerous N-terminal domain inhibitors are currently undergoing extensive clinical evaluation, it is important to understand the factors that may modulate in vivo susceptibility to these drugs. We recently reported that Wee1Swe1-mediated, cell cycle-dependent, tyrosine phosphorylation of Hsp90 affects GA binding and impacts cancer cell sensitivity to Hsp90 inhibition. This phosphorylation also affects Hsp90 ATPase activity and its ability to chaperone a selected group of clients, comprised primarily of protein kinases. Wee1 regulates the G2/M transition. Here we present additional data demonstrating that tyrosine phosphorylation of Hsp90 by Wee1Swe1 is important for Wee1Swe1 association with Hsp90 and for Wee1Swe1 stability. Yeast expressing non-phosphorylatable yHsp90-Y24F, like swe1∆ yeast, undergo premature nuclear division that is insensitive to G2/M checkpoint arrest. These findings demonstrate the importance of Hsp90 phosphorylation for proper cell cycle regulation.
Figures
Similar articles
-
Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function.Mol Cell. 2010 Feb 12;37(3):333-43. doi: 10.1016/j.molcel.2010.01.005. Mol Cell. 2010. PMID: 20159553 Free PMC article.
-
Hsp90 chaperone complexes are required for the activity and stability of yeast protein kinases Mik1, Wee1 and Swe1.Eur J Biochem. 2001 Apr;268(8):2281-9. doi: 10.1046/j.1432-1327.2001.02105.x. Eur J Biochem. 2001. PMID: 11298745
-
90-kDa heat shock protein inhibition abrogates the topoisomerase I poison-induced G2/M checkpoint in p53-null tumor cells by depleting Chk1 and Wee1.Mol Pharmacol. 2009 Jan;75(1):124-33. doi: 10.1124/mol.108.050807. Epub 2008 Sep 26. Mol Pharmacol. 2009. PMID: 18820127 Free PMC article.
-
Hsp90: chaperoning signal transduction.J Cell Physiol. 2001 Sep;188(3):281-90. doi: 10.1002/jcp.1131. J Cell Physiol. 2001. PMID: 11473354 Review.
-
Hsp90: Friends, clients and natural foes.Biochimie. 2016 Aug;127:227-40. doi: 10.1016/j.biochi.2016.05.018. Epub 2016 Jun 11. Biochimie. 2016. PMID: 27295069 Review.
Cited by
-
PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond.Front Pharmacol. 2024 Nov 5;15:1475998. doi: 10.3389/fphar.2024.1475998. eCollection 2024. Front Pharmacol. 2024. PMID: 39564119 Free PMC article. Review.
-
Regulation of molecular chaperones through post-translational modifications: decrypting the chaperone code.Biochim Biophys Acta. 2013 May;1829(5):443-54. doi: 10.1016/j.bbagrm.2013.02.010. Epub 2013 Feb 28. Biochim Biophys Acta. 2013. PMID: 23459247 Free PMC article. Review.
-
Post-translational modifications of Hsp90 and translating the chaperone code.J Biol Chem. 2020 Aug 7;295(32):11099-11117. doi: 10.1074/jbc.REV120.011833. Epub 2020 Jun 11. J Biol Chem. 2020. PMID: 32527727 Free PMC article. Review.
-
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.Oncotarget. 2012 Sep;3(9):954-87. doi: 10.18632/oncotarget.652. Oncotarget. 2012. PMID: 23006971 Free PMC article. Review.
-
Synthetic and Medicinal Chemistry Approaches Toward WEE1 Kinase Inhibitors and Its Degraders.ACS Omega. 2023 Jun 2;8(23):20196-20233. doi: 10.1021/acsomega.3c01558. eCollection 2023 Jun 13. ACS Omega. 2023. PMID: 37323408 Free PMC article. Review.
References
-
- Pearl LH, Prodromou C, Workman P. The Hsp90 molecular chaperone: an open and shut case for treatment. Biochem J 2008; 410:439–53. - PubMed
-
- Wandinger SK, Richter K, Buchner J. The Hsp90 chaperone machinery. J Biol Chem 2008; 283:18473–7. - PubMed
-
- Neckers L Heat shock protein 90: the cancer chaperone. J Biosci 2007; 32:517–30. - PubMed
-
- Rutherford SL, Lindquist S. Hsp90 as a capacitor for morphological evolution. Nature 1998; 396:336–42. - PubMed
-
- Zhao R, Davey M, Hsu YC, Kaplanek P, Tong A, Parsons AB, et al. Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone. Cell 2005; 120:715–27. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous